Banner

October 16, 2008

What Would Dennis Do?

7 Questions: Parexel-ClinPhone Deal

The ramifications of a deal that may never come to pass.

Tough Times

Quarterly Finances at etrials

Revenues are up, but etrials says it is reorganizing its strategy, with new sales staff and attention to service.

Four Cases Done, One Left

DataTrak Wins EDC Patent Case

In the latest installment of patent lawsuits roiling the electronic data capture industry, it’s not clear if the tussle is winding to a close. 

AstraZeneca, Datatrak

News Briefs

News bulletins for Monday, May 7.

thumbnail
What Would Dennis Do?

7 Questions: Parexel-ClinPhone Deal

February 20, 2008

By Mark Uehling

Little is known. But what’s there is tantalizing. Parexel International has offered to buy ClinPhone. ClinPhone has rebuffed the overture for now. Matters may go no farther. A merger of the two firms, now hypothetical, would change the conventional wisdom…

thumbnail
Tough Times

Quarterly Finances at etrials

August 20, 2007

By Mark Uehling

“It’s a ride, ride, ride, and there ain’t much cover.” That Bruce Springsteen lyric came to mind as we were listening to the etrials call with financial analysts last week. On the face of it, it should have been a…

thumbnail
Four Cases Done, One Left

DataTrak Wins EDC Patent Case

August 02, 2007

By Mark Uehling

After 18 months of jostling and three victories, Datasci lost a patent lawsuit against DataTrak, a Cleveland, Ohio electronic data capture (EDC) company. “Under the terms of the settlement agreement, no payment is required and Datasci has agreed to dismiss…

thumbnail
AstraZeneca, Datatrak

News Briefs

May 07, 2007

By info@clinpage.com

Russia is on track to become the next big clinical research market; global pharma R&D spending is projected to top $100 billion in 2007. That’s part of the State of the Clinical Trials Industry 2007, an annual sourcebook produced by…